» Articles » PMID: 18240922

Cerebrospinal Fluid Leakage into the Subdural Space: Possible Influence on the Pathogenesis and Recurrence Frequency of Chronic Subdural Hematoma and Subdural Hygroma

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2008 Feb 5
PMID 18240922
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Object: The purpose of this study was to clarify whether cerebrospinal fluid (CSF) leakage into the subdural space is involved in the genesis of chronic subdural hematoma (CSDH) and subdural hygroma (SH) and to clarify whether this leakage of CSF into the subdural space influences the postoperative recurrence rate of CSDH and SH.

Methods: In this prospective observational study, 75 cases involving patients treated surgically for CSDH (67 patients) or SH (8 patients) were evaluated with respect to clinical and radiological findings at presentation, the content of beta -trace protein (beta TP) in the subdural fluid (betaTPSF) and serum (betaTPSER), and the CSDH/SH recurrence rate. The betaTPSF was considered to indicate an admixture of CSF to the subdural fluid if betaTPSF/betaTPSER>2.

Results: The median beta TPSF level for the whole patient group was 4.29 mg/L (range 0.33-51 mg/L). Cerebrospinal fluid leakage, as indicated by betaTPSF/betaTPSER>2, was found to be present in 93% of the patients with CSDH and in 100% of the patients with SH (p=0.724). In patients who later had to undergo repeated surgery for recurrence of CSDH/SH, the betaTPSF concentrations (median 6.69 mg/L, range 0.59-51 mg/L) were significantly higher (p=0.04) than in patients not requiring reoperation (median 4.12 mg/L, range 0.33-26.8 mg/L).

Conclusions: As indicated by the presence of betaTP in the subdural fluid, CSF leakage into the subdural space is present in the vast majority of patients with CSDH and SH. This leakage could be involved in the pathogenesis of CSDH and SH. Patients who experience recurrences of CSDH and SH have significantly higher concentrations of betaTPSF at initial presentation than patients not requiring reoperation for recurrence. These findings are presented in the literature for the first time and have to be confirmed and expanded upon by further studies.

Citing Articles

Research on imaging biomarkers for chronic subdural hematoma recurrence.

Wu L, Zhu Y, Huang Q, Chen S, Zhou H, Xu Z Med Biol Eng Comput. 2024; 63(3):823-834.

PMID: 39500853 DOI: 10.1007/s11517-024-03232-7.


Medical management of chronic subdural hematoma with low-dose hydrocortisone: a case series.

Gurses M, Ulgen M, Gokalp E, Gecici N, Gungor A, Ture H Neurosurg Rev. 2024; 47(1):509.

PMID: 39212781 DOI: 10.1007/s10143-024-02763-9.


Chronic subdural hematoma: What precisely are we treating?.

Qiao Y, Alkarawi S, Provasek V, Zhang Y, Tsappidi S, Hui F Interv Neuroradiol. 2024; :15910199241263633.

PMID: 39034153 PMC: 11571133. DOI: 10.1177/15910199241263633.


Comparison of surgical strategies in patients with chronic subdural haematoma: a protocol for a network meta-analysis.

Li Y, Yang X, Zhou H, Hui X, Li H, Zheng J BMJ Open. 2023; 13(8):e070595.

PMID: 37597864 PMC: 10441052. DOI: 10.1136/bmjopen-2022-070595.


Natural course of chronic subdural hematoma following surgical clipping of unruptured intracranial aneurysm by pterional approach.

Kweon S, Kim S, Kwon M, Kim C, Kwon S, Ko Y J Cerebrovasc Endovasc Neurosurg. 2023; 25(4):390-402.

PMID: 37583078 PMC: 10774672. DOI: 10.7461/jcen.2023.E2023.04.017.